Siderophores; iron scavengers: the novel & promising targets for pathogen specific antifungal therapy

References

• Warnock DW. Trends in the epidemiology of invasive fungal infections. Jpn J Med Mycol. 2007;48:1–12.
   Google Scholar
• Binder U, Lass-Flörl C. Epidemiology of invasive fungal infections in the mediterranean area. Medit J Hemat Infect Dis. 2011;3(1):1–10.
   Google Scholar
• Brown GD, Denning DW, Levitz SM. Tackling human fungal infections. Science. 2012;336:647.
   PubMed Web of Science ®Google Scholar
• Lai CC, Tan CK, Huang YT, et al. Current challenges in the management of invasive fungal infections. J Infect Chemother. 2008;14:77–85.
   PubMedGoogle Scholar
• Low CY, Rotstein C. Emerging fungal infections in immunocompromised patients. F1000 Medicine Reports. 2011;3:14. DOI:10.3410/M3-14.
   PubMedGoogle Scholar
• Giri S, Kindo AJ. A review of Candida species causing blood stream infection. Indian J Med Microbiol. 2012;30(3):270–278.
   PubMed Web of Science ®Google Scholar
• Quindós G. Epidemiology of candidaemia and invasive candidiasis. A changing face. RevIberoamMicol. 2014;31(1):42–48.
   Google Scholar
• Filioti J, Spiroglou K, Panteliadis CP, et al. Invasive candidiasis in pediatric intensive care patients: epidemiology, risk factors, management, and outcome. Intensive Care Med. 2007;33:1272–1283.
   PubMed Web of Science ®Google Scholar
• Zaoutis T. Candidemia in children. Curr Med Res Opin. 2010;26:1761–1768.
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the infectious diseases society of America. Clin Infect Dis. 2008;46:327–360.
   PubMed Web of Science ®Google Scholar
• Steinbach WJ. Epidemiology of invasive fungal infections in neonates and children. ClinMicrobiol Infect. 2010;16:1321–1327.
   PubMed Web of Science ®Google Scholar
• Park BJ, Wannemuehler KA, Marston BJ, et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. Aids. 2009;23:525–530.
   PubMed Web of Science ®Google Scholar
• Mwaba P, Mwansa J, Chintu C, et al. Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions. Postgrad Med J. 2001;77:769–773.
   PubMed Web of Science ®Google Scholar
• Luma HN, Temfack E, Halle MP, et al. Cryptococcal meningoencephalitis in human immunodeficiency virus/acquired immunodeficiency syndrome in douala, cameroon: a cross sectional study. N Am J Med Sci. 2013;5(8):486–491.
   PubMedGoogle Scholar
• Lotholary O, Poizat G, Zeller V, et al. Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy. Aids. 2006;20:2183–2191.
   PubMed Web of Science ®Google Scholar
• Groll AH, Piscitelli SC, Walsh TJ. Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development. AdvPharmacol. 1998;44:343–500.
   Google Scholar
• Dutcher JD. The discovery and development of amphotericin B. Dis Chest. 1968;54(suppl 1):296–298.
   Google Scholar
• Brajtburg J, Powderly WG, Kobayashi GS, et al. Amphotericin B: current understanding of mechanisms of action. Antimicrob Agents Chemother. 1990;34(2):183–188.
   PubMed Web of Science ®Google Scholar
• Saliba F, Dupont B. Renal impairment and amphotericin B formulations in patients with invasive fungal infections. MedMycol. 2008;46(2):97–112.
   Google Scholar
• Chamilos G, Kontoyiannis DP. Update on antifungal drug resistance mechanisms of aspergillus fumigatus. Drug Resist Updat. 2005;8(6):344–358.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Gibbs DL, et al. Candida krusei, a multidrug- resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program, 2001 to 2005. J Clin Microbiol. 2008;46(2):515–521.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Messer SA, Hollis RJ, et al. Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007. J Clin Microbiol. 2009;47(10):3185–3190.
   PubMed Web of Science ®Google Scholar
• Lewis RE. Current concepts in antifungal pharmacology. Mayo Clinic Proceedings. 2011;86(8):805–817.
   PubMed Web of Science ®Google Scholar
• Walker SS, Xu Y, Triantafyllou I, et al. Discovery of a novel class of orally active antifungal β-1,3-d-glucan synthase inhibitors. Antimicrob Agents Chemother. 2011;55(11):5099–5106.
   PubMed Web of Science ®Google Scholar
• Perlin DS. Resistance to echinocandin class antifungal drugs. Drug Resist Updat. 2007;10(3):121–130.
   PubMed Web of Science ®Google Scholar
• Tandara L, Salamunic I. Iron metabolism: current facts and future directions. Biochem Med. 2012;22:311–328.
   PubMed Web of Science ®Google Scholar
• Ganz T. Iron in innate immunity: starve the invaders. Curr Opin Immunol. 2009;21:63–67.
   PubMed Web of Science ®Google Scholar
• Haas H, Eisendle M, Turgeon BG. Siderophores in fungal physiology and virulence. Annu Rev Phytopathol. 2008;46:149–187.
   PubMed Web of Science ®Google Scholar
• Kornitzer D. Fungal mechanisms for host iron acquisition. Curr Opin Microbiol. 2009;12(4):377–383.
   PubMed Web of Science ®Google Scholar
• Santos R, Buisson N, Knight S, et al. Haemin uptake and use as an iron source by Candida albicans: role of CaHMX1-encoded haem oxygenase. Microbiology. 2003;149:579–588.
   PubMed Web of Science ®Google Scholar
• Eisendle M, Oberegger H. Zadra I and Haas H. The siderophore system is essential for viability of Aspergillus nidulans: functional analysis of two genes encoding l-ornithine N5-monooxygenase (sidA) and a non-ribosomal peptide synthetase (sidC). Mol Microbiol. 2003;49:359–375.
   PubMed Web of Science ®Google Scholar
• Schrettl M, Bignell E, Kragl C, et al. Siderophore biosynthesis but not reductive iron assimilation is essential for Aspergillus fumigatus virulence. J Exp Med. 2004;200(9):1213–1219.
   PubMed Web of Science ®Google Scholar
• Schrettl M, Haas H. Iron homeostasis – achilles’ heel of aspergillus fumigatus?. Curr Opin Microbiol. 2011;14:400–405.
   PubMed Web of Science ®Google Scholar
• Haas H. Iron- A key nexus in the virulence of aspergillus fumigatus. Front Microbiol. 2012;3:28. DOI:10.3389/fmicb.2012.00028.
   PubMed Web of Science ®Google Scholar
• Nevitt T, Thiele DJ. Host iron withholding demands siderophore utilization for Candida glabrata to survive macrophage killing. PLoS Pathog. 2011;7(3):e1001322. DOI:10.1371/journal.ppat.1001322.
   PubMed Web of Science ®Google Scholar
• Haas H, Schoeser M, Lesuisse E, et al. Characterization of the aspergillus nidulans transporters for the siderophores enterobactin and triacetylfusarinine C. Biochem J. 2003;371:505–513.
   PubMed Web of Science ®Google Scholar
• Philpott CC, Protchenko O. Response to iron deprivation in saccharomyces cerevisiae. Eukaryotic Cell. 2008;7:20–27.
   PubMed Web of Science ®Google Scholar
• Van Der Helm D, Winkelmann G. Hydroxamates and polycarbonates as iron transport agents (siderophores) in fungi. In: Winkelmann G, Winge DR, editors. Metal ions in fungi. Decker: New York; 1994. p. 39–148.
   Google Scholar
• Renshaw JC, Robson GD, Trinci APJ, et al. Fungal siderophores: structures, functions and applications. Mycol Res. 2002;106(10):1123–1142.
   Web of Science ®Google Scholar
• Miethke M, Marahiel MA. Siderophore-based iron acquisition and pathogen control. Microbiol Mol Biol Rev. 2007;71:413–451.
   PubMed Web of Science ®Google Scholar
• Wallner A, Blatzer M, Schrettl M, et al. Ferricrocin, a siderophore involved in intra and transcellular iron distribution in aspergillus fumigatus. Appl Environ Microbiol. 2009;75:4194–4196.
   PubMed Web of Science ®Google Scholar
• Mootz HD, Schwarzer D, Marahiel MA. Ways of assembling complex natural products on modular nonribosomal peptide synthetases. Chembiochem. 2002;3:490–504.
   PubMed Web of Science ®Google Scholar
• Schafferer L, Beckmann N, Binder U, et al. AmcA—a putative mitochondrial ornithine transporter supporting fungal siderophore biosynthesis. Front Microbiol. 2015;6:252. DOI:10.3389/fmicb.2015.00252.
   PubMed Web of Science ®Google Scholar
• Hissen AH, Wan AN, Warwas ML, et al. The aspergillus fumigatus siderophore biosynthetic gene sidA, encoding L-ornithine N5-oxygenase, is required for virulence. Infect Immun. 2005;73(9):5493–5503.
   PubMed Web of Science ®Google Scholar
• Blatzer M, Schrettl M, Sarg B, et al. SidL, an aspergillus fumigatus transacetylase involved in biosynthesis of the siderophores ferricrocin and hydroxyferricrocin. Appl Environ Microbiol. 2011;77(14):4959–4966.
   PubMed Web of Science ®Google Scholar
• Schrettl M, Bignell E, Kragl C, et al. Distinct roles for intra- and extracellular siderophores during aspergillus fumigatus infection. PLoS Pathog. 2007;3(9):1195–1207.
   PubMed Web of Science ®Google Scholar
• Yasmin S, Alcazar-Fuoli L, Gründlinger M, et al. Mevalonate governs interdependency of ergosterol and siderophore biosyntheses in the fungal pathogen aspergillus fumigatus. Proc Natl Acad Sci U S A. 2012;109(8):E497–E504.
   PubMed Web of Science ®Google Scholar
• Haas H. Fungal siderophore metabolism with a focus on aspergillus fumigatus. Nat Prod Rep. 2014;31(10):1266–1276.
   PubMed Web of Science ®Google Scholar
• Schrettl M, Kim HS, Eisendle M, et al. SreA-mediated iron regulation in aspergillus fumigatus. Mol Microbiol. 2008;70(1):27–43.
   PubMed Web of Science ®Google Scholar
• Schrettl M, Beckmann N, Varga J, et al. HapX-mediated adaption to iron starvation is crucial for virulence of aspergillus fumigatus. PLoS Pathogens. 2010;6(9):e1001124.
   PubMed Web of Science ®Google Scholar
• Pao SS, Paulsen IT, Saier MH Jr. Major facilitator superfamily. Microbiol Mol BiolRev. 1998;62:1–34.
   PubMed Web of Science ®Google Scholar
• Winkelmann G. Siderophore transport in fungi. In: Winkelmann G, editor. Microbial transport systems. Weinheim, Germany: Wiley-VCH; 2001. p. 463–479.
   Google Scholar
• Heymann P, Gerads M, Schaller M, et al. The siderophore iron transporter of Candida albicans (Sit1p/Arn1p) mediates uptake of ferrichrome-type siderophores and is required for epithelial invasion. Infect. Immun. 2002;70:5246–5255.
   PubMed Web of Science ®Google Scholar
• Tangen KL, Jung WH, Sham AP, et al. The iron- and cAMP- regulated gene SIT1 influences ferrioxamine B utilization, melanization and cell wall structure in cryptococcus neoformans. Microbiology. 2007;153:29–41.
   PubMed Web of Science ®Google Scholar
• Lesuisse E, Blaiseau PL, Dancis A, et al. Siderophore uptake and use by the yeast saccharomyces cerevisiae. Microbiology. 2001;147:289–298.
   PubMed Web of Science ®Google Scholar
• Hsiang T, Baillie DL. Comparison of the yeast proteome to other fungal genomes to find core fungal genes. J Mol Evol. 2005;60:475–483.
   PubMed Web of Science ®Google Scholar
• Shakoury-Elizeh M, Tiedeman J, Rashford J, et al. Transcriptional remodeling in response to iron deprivation in saccharomyces cerevisiae. Mol Biol Cell. 2004;15:1233–1243.
   PubMed Web of Science ®Google Scholar
• Lan CY, Rodarte G, Murillo LA, et al. Regulatory networks affected by iron availability in Candida albicans. Mol Microbiol. 2004;53:1451–1469.
   PubMed Web of Science ®Google Scholar
• Oberegger H, Schoeser M, Zadra I, et al. SreA is involved in regulation of siderophore biosynthesis, utilization and uptake in aspergillus nidulans. Mol Microbiol. 2001;41:1077–1089.
   PubMed Web of Science ®Google Scholar
• Jung WH, Sham A, White R, et al. Iron regulation of the major virulence factors in the aids-associated pathogen cryptococcus neoformans. PLoS Biol. 2006;4(12):e410. DOI:10.1371/journal.pbio.0040410.
   Google Scholar
• Ueta R, Fujiwara N, Iwai K, et al. Mechanism underlying the iron dependent nuclear export of the iron-responsive transcription factor Aft1p in Saccharomyces cerevisiae. Mol Biol Cell. 2007;18:2980–2990.
   PubMed Web of Science ®Google Scholar
• Eisendle M, Schrettl M, Kragl C, et al. The intracellular siderophore ferricrocin is involved in iron storage, oxidative-stress resistance, germination, and sexual development in aspergillus nidulans. Eukaryot Cell. 2006;5:1596–1603.
   PubMed Web of Science ®Google Scholar
• Gsaller F, Eisendle M, Lechner BE, et al. The interplay between vacuolar and siderophore-mediated iron storage in aspergillus fumigatus. Metallomics. 2012;4(12):1262–1270.
   PubMed Web of Science ®Google Scholar
• Nairz M, Haschka D, Demetz E, et al. Iron at the interface of immunity and infection. Front Pharmacol. 2014;5:152. DOI:10.3389/fphar.2014.00152.
   PubMed Web of Science ®Google Scholar
• Ganz T, Nemeth E. Iron homeostasis in host defence and inflammation. Nat Rev Immunol. 2015;15(8):500–510.
   PubMed Web of Science ®Google Scholar
• Farnaud S, Evans RW. Lactoferrin-a multifunctional protein with antimicrobial properties. Mol Immunol. 2003;40:395–405.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Skinner AR. Ciclopirox for the treatment of superficial fungal infections: a review. Int J Dermatol. 2003;42(1):3–9.
   PubMed Web of Science ®Google Scholar
• Okamoto T, Tanida T, Wei B, et al. Regulation of fungal infection by a combination of amphotericin B and Peptide 2, a lactoferrin peptide that activates neutrophils. Clin Diagn Lab Immunol. 2004;11(6):1111–1119.
   PubMedGoogle Scholar
• Zarember KA, Cruz AR, Huang C-Y, et al. Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against aspergillusfumigatus. Antimicrob Agents Chemother. 2009;53(6):2654–2656.
   PubMed Web of Science ®Google Scholar
• Ibrahim AS, Gebremariam T, French SW, et al. The iron chelator deferasirox enhances liposomalamphotericin B efficacy in treating murine invasive pulmonary aspergillosis. J Antimicrob Chemother. 2010;65(2):289–292.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Kakeya H, Miyazaki T, et al. Synergistic antifungal effect of lactoferrin with azoleAntifungals against Candida albicans and a proposal for a new treatment method for invasive candidiasis. Jpn J Infect Dis. 2011;64:292–296.
   PubMed Web of Science ®Google Scholar
• Lin L, Pantapalangkoor P, Tan B, et al. transferrin iron starvation therapy for lethal bacterial and fungal infections. J Infect Dis. 2014;210(2):254–264.
   PubMed Web of Science ®Google Scholar
• Kondori N, Baltzer L, Dolphin GT, et al. Fungicidal activity of human lactoferrin-derived peptides based on the antimicrobial αβ region. Int J Antimicrob Agents. 2011;37(1):51–57.
   PubMed Web of Science ®Google Scholar
• Lai YW, Carter D, Campbell L, et al. Iron chelating agents as synergents in combination antifungal therapy. 18th International Society for Human and Animal Mycology. 2012. p. 17907.
   Google Scholar
• Mayadas TN, Cullere X, Lowell CA. The multifaceted functions of neutrophils. Annu Rev Pathol. 2014;9:181–218.
   PubMed Web of Science ®Google Scholar
• Correnti C, Strong RK. Mammalian siderophores, siderophore-binding lipocalins, and the labile iron pool. J Biol Chem. 2012;287(17):13524–13531.
   PubMed Web of Science ®Google Scholar
• Fluckinger M, Haas H, Merschak P, et al. Human tear lipocalin exhibits antimicrobial activity by scavenging microbial siderophores. Antimicrob Agents Chemother. 2004;48:3367–3372.
   PubMed Web of Science ®Google Scholar
• Leal SM, Roy S, Vareechon C, et al. targeting iron acquisition blocks infection with the fungal pathogens aspergillusfumigatus and fusarium oxysporum. PLoS Pathogens. 2013;9(7):e1003436.
   PubMed Web of Science ®Google Scholar
• Zhang D-L, Senecal T, Ghosh MC, et al. Hepcidin regulates ferroportin expression and intracellular iron homeostasis of erythroblasts. Blood. 2011;118(10):2868–2877.
   PubMed Web of Science ®Google Scholar
• Smith CL, Arvedson TL, Cooke KS, et al. IL-22 regulates iron availability in vivo through the induction of hepcidin. J Immunol. 2013;191(4):1845–1855.
   PubMed Web of Science ®Google Scholar
• Pinto LJ, Moore MM. Screening method to identify inhibitors of siderophore bio- synthesis in the opportunistic fungal pathogen, aspergillusfumigatus. Lett Appl Microbiol. 2009;49(1):8–13.
   PubMed Web of Science ®Google Scholar
• Balhara M, Ruhil S, Kumar M, et al. An anti-aspergillus protein from escherichia coli DH5α: Putative inhibitor of siderophore biosynthesis in aspergillusfumigatus. Mycoses. 2014;57:153–162.
   PubMed Web of Science ®Google Scholar
• Olucha J, Lamb AL. Mechanistic and structural studies of the N-hydroxylating flavoprotein monooxygenases. Bioorg Chem. 2011;39(5–6):171–177.
   PubMed Web of Science ®Google Scholar
• Franceschini S, Fedkenheuer M, Vogelaar NJ, et al. Structural Insight into the mechanism of oxygen activation and substrate selectivity of flavin-depndent hydroxylating monooxygenases. Biochemistry. 2012;51(36):7043–7045.
   PubMed Web of Science ®Google Scholar
• Badieyan S, Bach RD, Sobrado P. Mechanism of N-hydroxylation catalyzed by flavin-dependent monooxygenases. J Org Chem. 2015;80(4):2139–2147.
   PubMed Web of Science ®Google Scholar
• Qi J, Kizjakina K, Robinson R, et al. A fluorescence polarization binding assay to identify inhibitors of flavin-dependent monooxygenases. Anal Biochem. 2012;425(1):80–87.
   PubMed Web of Science ®Google Scholar
• Robinson R, Qureshi IA, Klancher CA, et al. Contribution to catalysis of ornithine binding residues in N5-monooxygenase. Arch Biochem Biophys. 2015;585:25–31.
   PubMed Web of Science ®Google Scholar
• Rodgers J, Stone TW, Barrett MP, et al. Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis. Brain. 2009;132:1259–1267.
   PubMed Web of Science ®Google Scholar
• Zwilling D, Huang SY, Sathyasaikumar KV, et al. Kynurenine3-monooxygenase inhibition in blood ameliorates neuro-degeneration. Cell. 2011;145:863–874.
   PubMed Web of Science ®Google Scholar
• Felnagle EA, Jackson EE, Chan YA, et al. Nonribosomal peptide synthetases involved in the production of medically relevant natural products. Mol Pharm. 2008;5(2):191–211.
   PubMed Web of Science ®Google Scholar
• Horbach R, Graf A, Weihmann F, et al. Sfp-type 4′-phosphopantetheinyl transferase is indispensable for fungal pathogenicity. Plant Cell. 2009;21:3379–3396.
   PubMed Web of Science ®Google Scholar
• Allen G, Bromley M, Kaye SJ, et al. Functional analysis of a mitochondrial phosphopantetheinyl transferase (PPTase) gene pptB in aspergillusfumigatus. Fungal Genet Biol. 2011;48:456–464.
   PubMed Web of Science ®Google Scholar
• Kosa NM, Foley TL, Burkart MD. Fluorescent techniques for discovery and characterization of phosphopantetheinyl transferase inhibitors. J Antibiot (Tokyo). 2014;67:113–120.
   PubMed Web of Science ®Google Scholar
• Koglin A, Walsh CT. Highlight: structural insights into nonribosomal peptide enzymatic assembly lines. Nat Prod Rep. 2009;26(8):987–1000.
   PubMed Web of Science ®Google Scholar
• Finking R, Neumüller A, Solsbacher J, et al. Aminoacyl adenylate substrate analogues for the inhibition of adenylation domains of nonribosomal peptide synthetases. Chembiochem. 2003;4(9):903–906.
   PubMed Web of Science ®Google Scholar
• Ferreras JA, Ryu JS, Di Lello F, et al. Small-molecule inhibition of siderophore biosynthesis in mycobacterium tuberculosis and yersiniapestis. Nat Chem Biol. 2005;1(1):29–32.
   PubMed Web of Science ®Google Scholar
• Somu RV, Boshoff H, Qiao C, et al. Rationally designed nucleoside antibiotics that inhibit siderophore biosynthesis of mycobacterium tuberculosis. J Med Chem. 2006;49(1):31–34.
   PubMed Web of Science ®Google Scholar
• Cisar JS, Tan DS. Small molecule inhibition of microbial natural product biosynthesis – an emerging antibiotic strategy. Chem Soc Rev. 2008;37(7):1320–1329.
   PubMed Web of Science ®Google Scholar
• Ueda H, Shoku Y, Hayashi N, et al. X-ray crystallographic conformational study of 5ʹ-O-[N-(L-alanyl)-sulfamoyl]adenosine, a substrate analogue for alanyl-tRNAsynthetase. BiochimBiophysActa. 1991;1080(2):126–134.
   PubMed Web of Science ®Google Scholar
• Cisar JS, Ferreras JA, Soni RK, et al. Exploiting ligand conformation in selective inhibition of non-ribosomal peptide synthetase amino acid adenylation with designed macrocyclic small molecules. J Am Chem Soc. 2007;129(25):7752–7753.
   PubMed Web of Science ®Google Scholar
• Stack D, Neville C, Doyle S. Nonribosomal peptide synthesis in aspergillusfumigatus and other fungi. Microbiology. 2007;153(5):1297–1306.
   PubMed Web of Science ®Google Scholar
• Lee TV, Johnson LJ, Johnson RD, et al. Structure of a eukaryotic nonribosomal peptide synthetaseadenylation domain that activates a large hydroxamate amino acid in siderophore biosynthesis. J Biol Chem. 2010;285(4):2415–2427.
   PubMed Web of Science ®Google Scholar
• Lee TV, Lott JS, Johnson RD, et al. Expression and purification of an adenylation domain from a eukaryotic non-ribosomal peptide synthetase: using structural genomics tools for a challenging target. Protein ExprPurif. 2010;74(2):162–168.
   PubMed Web of Science ®Google Scholar
• Sorensen JL, Knudsen M, Hansen FT, et al. Fungal NRPS-Dependent Siderophores: From Function to Prediction. Biosynthesis and Molecular Genetics of Fungal Secondary Metabolites Fungal Biology. 2014;317–339. doi: 10.1007/978-1-4939-1191-2_15.
   Google Scholar
• Bushley KE, Turgeon BG. Phylogenomics reveals subfamilies of fungal nonribosomal peptide synthetases and their evolutionary relationships. BMC Evol Biol. 2010;10:26. DOI:10.1186/1471-2148-10-26.
   PubMed Web of Science ®Google Scholar
• Galgóczy L, Nyilasi I, Papp T, et al. Are statins applicable for the prevention and treatment of zygomycosis? Clin Infect Dis. 2009;49(3):483–484.
   PubMed Web of Science ®Google Scholar
• Macreadie IG, Johnson G, Schlosser T, et al. Growth inhibition of Candida species and Aspergillus fumigatus by statins. FEMS Microbiol Lett. 2006;262:9–13.
   PubMed Web of Science ®Google Scholar
• Chamilos G, Lewis RE, Kontoyiannis DP. Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole. Antimicrob Agents Chemother. 2006;50(1):96–103.
   PubMed Web of Science ®Google Scholar
• Nyilasi I, Kocsubé S, Krizsán K, et al. In vitro synergistic interactions of the effects of various statins and azoles against some clinically important fungi. FEMS Microbiol Lett. 2010;307:175–184.
   PubMed Web of Science ®Google Scholar
• Brüggemann RJ, Alffenaar JW, Blijlevens NM, et al. Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other co-administered agents. Clin Infect Dis. 2009;48(10):1441–1458.
   PubMed Web of Science ®Google Scholar
• Miller MJ, Malouin F. Microbial iron chelators as drug delivery agents: the rational design and synthesis of siderophore-drug conjugates. Acc Chem Res. 1993;26:241–249.
   Web of Science ®Google Scholar
• Stearman R, Yuan DS, Yamaguchi-Iwai Y, et al. A permease-oxidase complex involved in high-affinity iron uptake in yeast. Science. 1996;271:1552–1557.
   PubMed Web of Science ®Google Scholar
• Wencewicz TA, Möllmann U, Long TE, et al. Is drug release necessary for antimicrobial activity of siderophore-drug conjugates? syntheses and biological studies of the naturally occurring salmycin “Trojan Horse” antibiotics and synthetic desferridanoxamine-antibiotic conjugates. Biometals. 2009;22(4):633–648.
   PubMed Web of Science ®Google Scholar
• Bernier G, Girijavallabhan V, Murray A, et al. Desketoneoenactin-siderophore conjugates for Candida: evidence of iron transport-dependent species selectivity. Antimicrob Agents Chemother. 2005;49(1):241–248.
   PubMed Web of Science ®Google Scholar
• Lupetti A, Welling MM, Pauwels EK, et al. Detection of fungal infections using radiolabeled antifungal agents. Curr Drug Targets. 2005;6:945–954.
   PubMed Web of Science ®Google Scholar
• Emery T, Hoffer PB. Siderophore-mediated mechanism of gallium uptake demonstrated in the microorganism ustilago sphaerogena. J Nucl Med. 1980;21:935–939.
   PubMed Web of Science ®Google Scholar
• Yokoyama A, Ohmomo Y, Horiuchi K, et al. Deferoxamine, a promising bifunctional chelating agent for labeling proteins with gallium: ga-67 DF-HAS—concise communication. J Nucl Med. 1982;23:909–914.
   PubMed Web of Science ®Google Scholar
• Petrik M, Haas H, Dobrozemsky G, et al. 68Ga-Siderophores for PET imaging of invasive pulmonary aspergillosis: proof of principle. J Nucl Med. 2010;51(4):639–645.
   PubMed Web of Science ®Google Scholar
• Haas H, Petrik M, Decristoforo C. An iron-mimicking, trojan horse-entering fungi—has the time come for molecular imaging of fungal infections? PLoS Pathog. 2015;11(1):e1004568. DOI:10.1371/journal.ppat.1004568
   Google Scholar